Literature DB >> 2506608

Effects of 1 week administration of two benzodiazepines on the sleep and early daytime performance of normal subjects.

J L Jurado1, R Fernández-Mas, A Fernández-Guardiola.   

Abstract

This study analyzed the effects of 1 week administration of alprazolam (AL; 0.25 mg), lorazepam (LO; 1 mg) and placebo (PL) on sleep as well as their residual effects on attention upon awakening. Under a crossed, double-blind design, six healthy male volunteer subjects between 19 and 30 years of age were studied. After two habituation sessions and a control session, each substance was given orally, twice a day for 7 days, with a 1-week washout period between administrations. At the end of each administration period, sleep studies were conducted from 2300 to 0700 hours. Evaluation of attention was carried out by means of a simple visuomotor reaction time (RT) task, and a time estimation (TE) task, that started at 0700 hours, lasting 1 h. Neither drug significantly affected any sleep variable. Both benzodiazepines tended to increase RT, but only LO did so significantly at the beginning of the attention test. No significant changes in predictive and failure responses during the RT task were produced by either drug. Also, no significant changes were observed in the TE. Even though only LO produced a significant increase of RT at the selected doses and with 1 week administration, it is suggested that both benzodiazepines could have residual effects on attention.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506608     DOI: 10.1007/bf00634459

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  7 in total

1.  Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard.

Authors:  T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda
Journal:  Psychiatry Clin Neurosci       Date:  2001-06       Impact factor: 5.188

2.  The continuing problem of false positives in repeated measures ANOVA in psychophysiology: a multivariate solution.

Authors:  M W Vasey; J F Thayer
Journal:  Psychophysiology       Date:  1987-07       Impact factor: 4.016

3.  Polygraphic study in man to differentiate sleep-inducing action of hypnotics.

Authors:  A Fernandez-Guardiola; A Lerdo de Tejada; C Contreras; A Salgado; F Ayala
Journal:  Psychopharmacologia       Date:  1972

4.  Are electroencephalographic and psychomotor measures sensitive in detecting residual sequelae of benzodiazepine hypnotics?

Authors:  H Ott
Journal:  Psychopharmacology Suppl       Date:  1984

5.  Sedative effects and impaired learning and recall after single oral doses of lorazepam.

Authors:  R I Shader; D Dreyfuss; J R Gerrein; J S Harmatz; S J Allison; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1986-05       Impact factor: 6.875

6.  Chronic use of benzodiazepines and psychomotor and cognitive test performance.

Authors:  I Lucki; K Rickels; A M Geller
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

7.  Effects of alprazolam and diazepam on the daytime sleepiness of non-anxious subjects.

Authors:  W F Seidel; S A Cohen; L Wilson; W C Dement
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  7 in total
  2 in total

1.  Effects of Passion Flower Extract, as an Add-On Treatment to Sertraline, on Reaction Time in Patients ‎with Generalized Anxiety Disorder: A Double-Blind Placebo-Controlled Study.

Authors:  Mandana Nojoumi; Padideh Ghaeli; Samrand Salimi; Ali Sharifi; Firoozeh Raisi
Journal:  Iran J Psychiatry       Date:  2016-07

2.  The Effect of Chronic Alprazolam Intake on Memory, Attention, and Psychomotor Performance in Healthy Human Male Volunteers.

Authors:  Zahid Sadek Chowdhury; Mohammed Monzur Morshed; Mohammad Shahriar; Mohiuddin Ahmed Bhuiyan; Sardar Mohd Ashraful Islam; Muhammad Shahdaat Bin Sayeed
Journal:  Behav Neurol       Date:  2016-07-04       Impact factor: 3.342

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.